AI-generated summary
The authors randomized 40 people with seasonal affective disorder to five weeks of either fluoxetine with placebo light or bright light with placebo drug, and report that response rates were similar, 70% for bright light and 65% for fluoxetine. A remission rate that tended to favor bright light did not reach statistical significance. The authors state that a larger sample is needed to confirm any advantage of bright light.
- Participants
- 40
- Who or what was studied
- Adults with seasonal affective disorder (winter type) per DSM-III-R and a Hamilton Depression Scale score of at least 16
- Limits stated in the abstract
- The authors note the apparently better response to bright light requires confirmation in a larger sample, and the sample was small with 35 of 40 completing treatment.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on cambridge.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Lux. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.